Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice

Japanese Journal of Cancer Research

Volumn 89, Issue 11, 1998, Pages 1144-1153

  Takechi, Teiji ^a   Okabe, Hiroyuki ^a   Fujioka, Akio ^a   Murakami, Yuko ^a   Fukushima, Masakazu ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 Fluorouracil sensitivity; Dihydropyrimidine dehydrogenase; Post transcriptional control; Semi quantitative RT PCR; Tumor growth

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL DENSITY; CELL GROWTH; CYTOSOL; FIBROSARCOMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH CURVE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RADIOENZYMATIC ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 0032415957     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00509.x     Document Type: Article

References (22)

1. Heggie, G. D., Sommadossi, J. P., Cross, D. S., Huster, W. J. andDiasio, R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile. Cancer Res., 47, 2203-2206 (1987).
2. Etienne, M. C., Cheradame, S., Fischel, J. L., Formento, P., Dassonville, O., Renee, N., Schneider, M., Thyss, A., Demard, F. andMilano, G. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J. Clin. Oncol., 13, 1663-1670 (1995).
3. Milano, G., Fischel, J. L., Spector, T., Etienne, M. C. andFormento, P. Enhancement of fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with 5-ethynyluracil. Proc. Am. Assoc. Cancer Res., 36, 292 (1995).
4. Porter, D. J. T., Chestnut, W. G., Merrill, B. M. and Spector, T. Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluraciI. J. Biol. Chem., 267, 5236-5242 (1992).
5. Spector, T., Harrington, J. A. andPorter, D. J. T. 5-Ethynyluracil (776C85): inactivation of dihydropyrimidine dehydrogenase in vivo. Biochem. Pharmacol., 46, 2243-2248 (1993).
6. Takechi, T., Uchida, J., Fujioka, A. andFukushima, M. Enhancing 5-fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with uracil in human tumor cells. Int. J. Oncol., 11, 1041-1044 (1997).
7. Takechi, T., Uchida, J., Takeda, S. andFukushima, M. Enhancement of 5-fluorouracil cytotoxicity by dihydropyrimidine dehydrogenase inhibitor, 5-chloro-2,4-dihydroxypyridine. Proc. Jpn. Cancer Assoc., 87 (Suppl.), 639 (1996) (in Japanese).
8. Tatsumi, K., Fukushima, M., Shirasaka, T. andFujii, S. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn. J. Cancer Res., 78, 748-755 (1987).
9. McLeod, H. L., Sludden, J., Murray, G. I., Keenan, R. A., Davidson, A. I., Park, K., Koruth, M. andCassidy, J. Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br. J. Cancer, 77, 461-465 (1998).
10. Williams, C. S. andTuchman, M. Correlations of dihydropyrimidine dehydrogenase, thymidine phosphorylase and thymidine kinase activities in strongly and weakly malignant cultured murine neuroblastoma cells. Int. J. Cancer, 43, 901-904 (1989).
11. Rasheed, S., Walter, A., Nelson-Rees, W. A., Toth, E. M., Arnstein, P. andGardner, M. B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer, 33, 1027-1033 (1974).
12. Yunis, A. A., Arimura, G. K. andRussin, D. J. Human pancreatic carcinoma (MIAPaCa-2) in continuous culture: sensitivity to asparaginase. Int. J. Cancer, 19, 218-235 (1977).
13. Naguib, F. N. M., el Kouni, M. H. andCha, S. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res., 45, 5405-5412 (1985).
14. Ikenaka, K., Shirasaka, T., Kitano, S. andFujii, S. Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann, 70, 353-359 (1979).
15. Yokota, H., Fernandez-Salguero, P., Furuya, H., Lin, K., McBride, O. W., Podschun, B., Schnackerz, K. D. andGonzalez, F. J. cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria. J. Biol. Chem., 269, 23192-23196 (1994).
16. Tokunaga, K., Nakamura, Y., Sakata, K., Fujimori, K., Ohkubo, M, Sawada, K. andSakiyama, S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res., 47, 5616-5619 (1987).
17. Johnson, M. R., Wang, K., Tillmanns, S., Albin, N. andDiasio, R. B. Structural organization of the human dihydropyrimidine dehydrogenase gene. Cancer Res., 57, 1660-1663 (1997).
18. Ercolani, L., Florence, B., Denaro, M. andAlexander, M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene, J. Biol. Chem., 263, 15335-15341 (1988).
19. Thein, S. L. andWallace, R. B. "Human Genetic Diseases: A Practical Approach," pp. 33-50 (1986). IRL Press, Herndon, VA.
20. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D. andMitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942 (1987).
21. Sabath, D. E., Broome, H. E. andPrystowsky, M. B. Glyc-eraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene, 91, 185-191 (1990).
22. Murphy, L. D., Herzog, C. E., Rudick, J. B., Fojo, A. T. andBates, S. E. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry, 29, 10351-10356 (1990).